Kenneth J. Caldwell

Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery

Dalia Haydar, Haley Houke, Jason Chiang et al. · Neuro-Oncology · 2020 · 136 citations · Full text

The ENHANCE-3 study: venetoclax and azacitidine plus magrolimab or placebo for untreated AML unfit for intensive therapy

Naval Daver, Paresh Vyas, Gerwin Huls et al. · Blood · 2025 · 27 citations · Full text

Endothelin-1 Induced Middle Cerebral Artery Occlusion Model for Ischemic Stroke with Laser Doppler Flowmetry Guidance in Rat

Saeed Ansari, Hassan Azari, Kenneth J. Caldwell et al. · Journal of Visualized Experiments · 2013 · 26 citations · Full text

A newborn with a large <i>NTRK</i> fusion positive infantile fibrosarcoma successfully treated with larotrectinib

Kenneth J. Caldwell, Esther De La Cuesta, Cara E. Morin et al. · Pediatric Blood & Cancer · 2020 · 21 citations

Phase I expansion cohort to evaluate the combination of bevacizumab, sorafenib and low-dose cyclophosphamide in children and young adults with refractory or recurrent solid tumours

Sara M. Federico, Kenneth J. Caldwell, M. Beth McCarville et al. · European Journal of Cancer · 2020 · 19 citations · Full text

Recurrent Solid Tumours, Medicine, Low-dose Cyclophosphamide +7